Skip to main navigation
Skip to search
Skip to main content
Arizona State University Home
Search content at Arizona State University
Home
Profiles
Departments and Centers
Scholarly Works
Activities
Equipment
Grants
Datasets
Prizes
A novel combination therapy with nuclear export inhibitor selinexor and oncolytic virus for lung and metastatic cancers
Rahman, Masmudur
(PI)
Immunotherapy, Vaccines and Virotherapy, Center for (CIVV)
Project
:
Research project
Overview
Fingerprint
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Selinexor
100%
Lung Cancer
100%
Combination Therapy
100%
Oncolytic Virus
100%
Metastatic Carcinoma
100%
Nuclear Export
100%
Lung
44%
Cancer Cell
22%
Malignant Neoplasm
22%
Immune Response
22%
Neoplasm
22%
Tumor Virus
11%
Lung Metastasis
11%
Cell Proliferation
11%
Immune Checkpoint Inhibitor
11%
Diseases
11%
Virus
11%
Immunotherapy
11%
Cancer Model
11%
Pharmacology, Toxicology and Pharmaceutical Science
Selinexor
100%
Combination Therapy
100%
Lung Cancer
100%
Oncolytic Virus
100%
Malignant Neoplasm
44%
Neoplasm
22%
Tumor Virus
11%
Lung Metastasis
11%
Diseases
11%
Immune Checkpoint Inhibitor
11%
Cancer Model
11%
Immunotherapy
11%
Virus
11%